About Alexandra Sakatos
Alexandra Sakatos is a co-founder, CEO and director at Ancilia Biosciences.
Alexandra Sakatos first appears on SEC filings in 2023.
Experience
This experience comes from Alexandra Sakatos's profile and from SEC filings. For roles taken from filings, the years are when the filings name Alexandra Sakatos in the role, so the role may have started earlier or lasted longer.
Ancilia Biosciences, Inc. Current
Co-founder, CEO and director
Co-Founder & CEO (2019 – Present)
2019 – Present · New York, NY
Develops virus-resistant bacterial therapies for human health and other uses.
DV
Deep Science Ventures
Venture Founder
2018 – 2019
HU
Harvard University
Doctoral Researcher
2010 – 2016
SS
Salk Institute for Biological Studies
Research Assistant
2007 – 2010
CY
Columbia University in the City of New York
Analytics Intern
2009
Key Colleagues at Startups
The people Alexandra Sakatos works with at each company, as listed on that company's latest Form D.
Ancilia Biosciences, Inc. · Form D, Apr 6, 2026
Rodolphe Barrangou
Co-founder, CSO / Part Time and director
DP
Dale Pfost
Director
VS
Vera Schroeder
Director
Gurdane Bhutani
Director